JESÚS FERNANDO
SAN MIGUEL IZQUIERDO
Researcher in the period 1986-2013
Hadassah Medical Center
Jerusalén, IsraelPublications in collaboration with researchers from Hadassah Medical Center (7)
2023
2015
-
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
New England Journal of Medicine, Vol. 372, Núm. 2, pp. 142-152
2009
-
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: Impact of a dose-modification guideline
British Journal of Haematology, Vol. 144, Núm. 6, pp. 895-903
2008
-
Efficacy and safety of bortezomib in patients with renal impairment: Results from the APEX phase 3 study
Leukemia, Vol. 22, Núm. 4, pp. 842-849
2007
-
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: Final time-to-event results of the APEX trial
Blood, Vol. 110, Núm. 10, pp. 3557-3560
-
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma
British Journal of Haematology, Vol. 137, Núm. 5, pp. 429-435
2005
-
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
New England Journal of Medicine, Vol. 352, Núm. 24, pp. 2487-2498